博雅生物(300294.SZ):截至目前,公司暂无相关并购计划

Group 1 - The company is focused on industry development trends and strategic opportunities that enhance its core competitiveness and create long-term value [1] - The company acknowledges that external mergers and acquisitions carry significant uncertainty [1] - Currently, the company has no plans for related mergers and acquisitions [1]

China Resources Boya Bio-pharmaceutical -博雅生物(300294.SZ):截至目前,公司暂无相关并购计划 - Reportify